Understanding your prognosis and the factors that affect it
Hodgkin lymphomais one of the most curable forms of cancer.
For example, you may see one-year, five-year, or 10-year survival rates.
These numbers describe how long someone with any stage of Hodgkin lymphoma and other factors is expected to live.
istockphoto
Survival Rate After Relapse
More than half of recurrences occur within two years of primary treatment.
Up to 90% of recurrences happen before the five-year mark.
The occurrence of relapse after 10 years is rare.
After 15 years, developing lymphoma is the same as its risk in the normal population.
Even with a recurrence, many people with Hodgkin lymphoma go on to live long lives.
Factors That Affect Survival
Some variables can increase or decrease the chance of surviving Hodgkin lymphoma.
Less toxic chemotherapy and small-field radiation therapy reduce treatment side effects.
They may also potentially reduce the long-term side effects of the disease.
Estimate Your Prognosis
TheHasenclever prognostic toolcan estimate prognosis based on seven factors or risks.
According to the tool, each factor reduces five-year survival by about 8%.
For people with five or more risk factors, the estimated five-year survival rate is 56%.
Keep in mind that these tools estimate “average” prognosis, and nobody is average.
The long-term side effects of Hodgkin lymphoma, like secondary cancers, will require lifelong monitoring.
Many cancer clinics now have active cancer rehabilitation programs.
There, they can fully address thelate effects of cancer treatment, ranging from chronic pain to anxiety.
The prognosis is better for Hodgkin lymphoma than for non-Hodgkin lymphoma.
American Cancer Society.Cancer facts & figures 2019.
Brown JC, Winters-Stone K, Lee A, Schmitz KH.Cancer, physical activity, and exercise.Compr Physiol.
Shanbhag S, Ambinder RF.Hodgkin lymphoma: a review and update on recent progress.CA Cancer J Clin.
2014;8(2):21-6.
PMID: 24800035; PMCID: PMC4003439.
Surveillance, Epidemiology, and End Results Program.SEER Cancer Statistics Review (CSR) 1975-2014.
